Skip to main content

Table 2 Characteristics of the subjects in both groups after taking drugs for 8 weeks

From: LDL-cholesterol lowering effect of a generic product of simvastatin compared to simvastatin (Zocor™) in Thai hypercholesterolemic subjects – a randomized crossover study, the first report from Thailand

Parameters mean ± standard deviation (90 % confidence interval) P-value
  1st group (N = 22) 2nd group (N = 19)  
Total cholesterol (mg/dL) 191.80 ± 37.41 198.90 ± 31.48 NS
  (178.37–205.23) (187.02–210.78)  
HDL (mg/dL) 45.50 ± 8.38 50.80 ± 10.49 NS
  (42.49–48.51) (46.84–54.76)  
Triglyceride (mg/dL) 140.90 ± 69.49 129.20 ± 78.59 NS
  (115.96–165.84) (99.54–158.86)  
LDL (mg/dL) 118.20 ± 30.92 122.30 ± 22.43 NS
  (107.10–129.30) (113.84–130.76)  
SGOT (U/L) 28.60 ± 12.71 28.50 ± 15.35 NS
  (24.04–33.16) (22.71–34.29)  
SGPT (U/L) 35.80 ± 27.02 34.80 ± 26.71 NS
  (26.10–45.50) (24.72–44.88)  
CPK (U/L) 125.80 ± 55.61 119.60 ± 57.17 NS
  (105.84–145.76) (98.02–141.76)